Type 2 diabetes is increasing in epidemic proportions
worldwide, and is strongly associated with atherosclerotic
cardiovascular disease (CVD). Hyperglycaemia increases risk of
CVD, but glycaemic control does not substantially reduce CVD
risk. There are several potential explanations for this apparent
paradox, including the roles of the metabolic syndrome and
post-load hyperglycaemia in the association of type 2 diabetes
and CVD.